CROSSWORD

12345678910
Across
  1. 3. FDA approved biological for treatment of Generalised Pustular Psoriasis for age >12 years.
  2. 7. New species causing epidemic of severe antifungal resistant tinea.
  3. 9. FDA approved in 2024 for treating primary axillary hyperhidrosis for age > 9 years.
  4. 10. Dry Birch bark extract recently FDA approved for topical treatment in junctional EB.
Down
  1. 1. Drug approved in 2024 for treatment of WHIM syndrome.
  2. 2. Alkaloid derived from fire ants recently discovered having structure similar to ceramides.
  3. 4. NO releasing agent recently FDA approved for topical treatment for Molluscum Contagiosum for >1 year.
  4. 5. Antibiotic recently approved by US-FDA as a part of the fixed dosed triple combination therapy for acne for >12 years.
  5. 6. Highly selective bruton tyrosine kinase inhibitor under phase 3 trial for CSU.
  6. 8. PDE4 Inhibitor recently approved for usage in children >6 years with moderate – severe plaque psoriasis.